Press release
Taurox (TAUX) Overshadows Shiba Inu (SHIB) JUL-AI Governance Launch, Smart Money Shifts After $314K
Shiba Inu deployed JUL-AI, an AI-powered governance tool for managing DAO decisions and expanding the metaverse. The announcement generated temporary interest, but the numbers tell a different story. SHIB has roughly 15,000 daily active users and adds fewer than 100 new accounts per day.Building AI governance infrastructure for a community that small creates overhead without a user base large enough to justify it. Governance layers require participation, and participation requires active users who actually engage. SHIB is stacking governance tooling on a shrinking foundation.
Taurox (https://taurox.io/) is a decentralized hedge fund where AI agents will execute trades across exchanges using pooled capital once the presale concludes and the pool goes live. AI in Taurox generates trading returns for stakers. AI in SHIB generates governance proposals that fewer than 100 new users per day will ever vote on.
How Taurox Stakers Withdraw Capital on Their Own Terms
Stakers submit txTokens to the withdrawal contract, which calculates redemption value directly from the pool's current net asset value. Each staker receives their proportional share of pool assets including all accrued returns from agent trading activity. The txTokens burn upon redemption, removing them from circulation permanently and reducing the outstanding claim on pool assets.
The protocol maintains a 15% stablecoin reserve at all times, ensuring withdrawal liquidity is available without forcing asset sales or creating slippage. Partial withdrawals are fully supported, so stakers can pull a portion of their position while keeping the rest active and generating returns. Only the staker can initiate their own withdrawal. No agent, no external party, and no protocol administrator can trigger the process for someone else.
Stakers keep 80% of net profits at the standard tier, and the withdrawal mechanism ensures they can access those profits on their own schedule without waiting for approval. SHIB built a governance AI for a shrinking user base with declining daily accounts. Taurox (https://taurox.io/) built withdrawal mechanics that give stakers complete control over their capital and returns.
Phase 2 Entry Carries Real Market Proof Behind It
Phase 1 of the TAUX (https://taurox.io/) presale sold out in under 24 hours at $0.01. Phase 1 buyers are up 20% at the current Phase 2 price of $0.012. The presale has raised $314.7K, and Phase 2 is 23.9% filled. Each phase has a fixed allocation that closes permanently when sold out. The price steps up, and the previous entry is gone forever. There are no extensions, no repricing, and no second chances. SHIB launched an AI governance tool for a network adding fewer than 100 new accounts daily.
TAUX presale participants are entering a protocol where staking activates at the end of the presale and agents begin trading real capital against live markets. One project adds features to a declining user base. The other builds trading infrastructure for a growing pool of capital. Phase 2 is filling, and the $0.012 entry disappears permanently when the allocation runs out. Waiting means paying more for the same position in the same protocol. The cheapest entries are always the ones that close first.
TAUX at $0.012: Full Number Breakdown
Phase 2 is live at $0.012. Listing at $0.08 delivers 6.67x from the current entry. A $1 post-listing price represents 100x. At a $1 billion pool with 30% gross returns, implied TAUX price reaches $1.85, or x154 from today. Zero management fees anywhere. The protocol charges 5% on profits only. Thirty percent of collected fees burn permanently as TAUX tokens.
The remaining 70% funds the DAO treasury for ongoing development. Supply is fixed at 2 billion tokens with no minting function. Every fee cycle compresses circulating supply against a ceiling that never moves upward. The presale has raised $314.7K, and Phase 2 is 23.9% filled. Phase 2 is filling now.
Learn More
Buy TAUX: https://taurox.io/
Whitepaper: https://docs.taurox.io/
Official Telegram: https://t.me/tauroxlabs
Contact: Samuel Pierce
Email: Samuel@IgnixMedia.com
Decentralized, non-custodial protocol connecting capital with autonomous trading agents.
Algorithmic allocation. Transparent performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Taurox (TAUX) Overshadows Shiba Inu (SHIB) JUL-AI Governance Launch, Smart Money Shifts After $314K here
News-ID: 4433964 • Views: …
More Releases from Ignix Media
Every 38-Day Fear Streak in Crypto History Ended the Same Way. Every Single One
The Fear and Greed Index has been pinned below 25 for 38 consecutive days. Every historical streak of this length led to a substantial market rally within the following months. Whale wallets accumulated 270,000 BTC worth $23B during this window, the largest concentration of informed buying since mid-2022. Altcoins are near all-time lows against Bitcoin at 57.1% dominance. The Fed held rates at 3.50-3.75% while hot PPI data showed +0.7%,…
Your Crypto Portfolio in 12 Months Hinges on One Decision You Make This Week
What your portfolio looks like a year from now is being decided right now. The Fear and Greed Index has held below 25 for 38 consecutive days, marking the longest extreme fear streak since mid-2022. Whale wallets loaded 270,000 BTC worth $23B during this window. Altcoins sit near all-time lows against Bitcoin dominance at 57.1%. The Fed held rates at 3.50-3.75%, hot PPI printed +0.7%, and $334M in leveraged longs…
Whales Moved $23B in 38 Days of Fear. Retail Missed the Entire Chess Move
Whale wallets accumulated 270,000 BTC worth $23B over the past 38 days while the Fear and Greed Index held below 25. Retail sold into every red candle. The pattern reads like a chess endgame: one side sacrifices material while the other quietly builds a winning position. Bitcoin dominance climbed to 57.1% as altcoins bled to near all-time lows. The Fed held rates at 3.50-3.75% after hot PPI data printed +0.7%,…
Prediction Models All Flagged This 38-Day Fear Streak. What One Asset Did Next.. …
Every prediction model tracking crypto sentiment has flagged the same anomaly. The Fear and Greed Index has stayed below 25 for 38 consecutive days, the longest extreme fear streak since mid-2022. Whale wallets accumulated 270,000 BTC worth $23B during this window while retail capitulated in waves. The pattern is consistent with historical bottoms where informed capital loads positions and smaller holders sell at the worst possible moment. Liquidation cascades hit…
More Releases for Phase
Single-Phase and Three-Phase Amplifiers: An Innovative Solution to Overcome Sing …
I. Rural Power Grid Upgrades: Solving Power Supply Challenges in Remote AreasChallenges:In remote rural areas, long supply radii and scattered users, combined with single-phase power supply, lead to unstable end-point voltages and insufficient power, making it difficult to meet the electricity demands of modern home appliances and agricultural machinery.Benefits:Improved Voltage Quality: By converting single-phase power into balanced three-phase output, line losses are reduced, resolving the issue of low end-point voltages.Expanded…
Clinical Trials by Phase (Phase I, Phase II, Phase III, Phase IV) Market Forecas …
A clinical trial is a research study, where a group of people is given a test or treatment. Clinical trials study the safety and efficacy of tests and treatments. If the test or treatment is safe and meets regulatory requirements, then it is approved as a standard of care.
Download Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00006203/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
IQVIA
Parexel International Corporation
Charles River Laboratories
ICON plc
SGS SA
Chiltern International Ltd
Syneos Health
PRA Health Sciences
Wuxi AppTec Inc
Pharmaceutical Product Development,…
Digital Phase Shifters Market
Digital Phase Shifters Market A recently identified vacuum in the literature about the creation of digital phase shifters for modern communication systems is attempted to be filled in the book Design of Digital Phase Shifters for Multipurpose Communication Systems. By significantly reducing RF power consumption and improving noise immunity, directed beams enhance the development of new-generation mobile communication systems. In this regard, digital phase shifters in particular, which are part…
COVID-19 - Pipeline Analysis 2020 for Global Market | Emphasis on Products cover …
COVID-19 (also known as Anderson COVID-19)?is a viral disease caused by RNA virus, SARS-CoV-2 or commonly known as corona virus. These viruses can cause respiratory, enteric, hepatic, and neurologic diseases. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China. It rapidly spread, resulting in an epidemic throughout China, followed by an increasing number of cases in other…
Power Metering Market Information by type (smart, digital, analog), by phase (si …
Power Metering Market Information by type (smart, digital, analog), by phase (single phase, three phase) by application (residential, commercial and industrial) and Region - Forecast to 2022
The report for Global Power Metering Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and…
HIV Vaccines Market Perceive Aggrandized Growth at a CAGR of 11.48% Till 2023 | …
HIV Vaccines Market Report Added on MarketResearchFuture.com with Overall Analysis. Key developments and Strategies Cover in this Report. The Market for Expected to Grow Globally Over the CAGR of 5 % During the Period 2018 to 2027 from USD 2,702.3 Billion in 2027.
HIV Vaccines Market - Segmentation
The global HIV vaccines market has been segmented on the basis of basis of antibiotics, type, and lastly, region.
Antibiotics have been segmented into dicloxacillin,…
